Details of the Drug

General Information of Drug (ID: DMCFPBE)

Drug Name

NN8765

Indication

Disease Entry	ICD 11	Status	REF
Rheumatoid arthritis	FA20	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
NKG2-A/B-activating NK receptor (NKG2A)	TTC4IMS	NKG2A_HUMAN	Modulator	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Clinical pipeline report, company report or official report of Innate Pharma.
2	Handbook of Therapeutic Antibodies. 2014. 1. Page(1098).